PBYI Puma Biotechnology, Inc.
Puma Biotechnology, Inc. (PBYI) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
How much of that selling was preplanned? 95% planned / 5% discretionary
Largest single sale: $567.0K.
Where they traded
No open-market insider purchase on record.
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Cesano Alessandra | Director | Sell 10b5-1 | 62,150 | $9.12 | $567.0K | 56,700 −52.3% of holding | |
| WILSON TROY EDWARD | Director | Sell 10b5-1 | 5,000 | $9.10 | $45.5K | 54,750 −8.4% of holding | |
| AUERBACH ALAN H | President and CEO | Sell 10b5-1 | 44,058 | $8.26 | $364.1K | 7,261,671 −0.6% of holding | |
| NOUGUES MAXIMO F | Chief Financial Officer | Sell 10b5-1 | 9,386 | $8.26 | $77.6K | 230,637 −3.9% of holding | |
| HUNT DOUGLAS M | See Remarks | Sell 10b5-1 | 8,460 | $8.26 | $69.9K | 196,841 −4.1% of holding | |
| Senderowicz Adrian | Director | Sell 10b5-1 | 27,000 | $7.20 | $194.3K | 27,000 −50% of holding | |
| MOYES JAY M | Director | Sell 10b5-1 | 22,000 | $7.22 | $158.8K | 58,322 −27.4% of holding | |
| Dorval Allison | Director | Sell 10b5-1 | 11,610 | $7.20 | $83.6K | 90,780 −11.3% of holding | |
| WILSON TROY EDWARD | Director | Sell 10b5-1 | 10,800 | $7.20 | $77.7K | 59,750 −15.3% of holding | |
| Stuglik Brian M | Director | Sell 10b5-1 | 8,100 | $7.20 | $58.3K | 113,858 −6.6% of holding | |
| AUERBACH ALAN H | President and CEO | Sell 10b5-1 | 18,012 | $5.88 | $105.9K | 7,145,951 −0.3% of holding | |
| NOUGUES MAXIMO F | Chief Financial Officer | Sell 10b5-1 | 6,405 | $5.88 | $37.7K | 193,284 −3.2% of holding | |
| HUNT DOUGLAS M | See Remarks | Sell 10b5-1 | 5,014 | $5.88 | $29.5K | 155,907 −3.1% of holding | |
| AUERBACH ALAN H | President and CEO | Sell 10b5-1 | 16,938 | $5.84 | $99.0K | 7,163,963 −0.2% of holding | |
| NOUGUES MAXIMO F | Chief Financial Officer | Sell 10b5-1 | 4,540 | $5.84 | $26.5K | 199,689 −2.2% of holding | |
| HUNT DOUGLAS M | See Remarks | Sell 10b5-1 | 3,973 | $5.84 | $23.2K | 160,921 −2.4% of holding | |
| MILLER MICHAEL PATRICK | Director | Sell | 20,000 | $4.86 | $97.2K | 54,000 −27% of holding |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.